Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,965-20,976 of 23,847
Drug study icon
CompletedNCT05454410

MIJ821 for treatment-resistant depression

This study is completed in the United States, in Japan, in Poland, .... It is testing MIJ821 for treatment-resistant depression.

Multiple locations, including Birmingham
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Japan, Poland, ...
Sponsor
Novartis Pharmaceuticals
Condition
Depression
Drug study icon
TerminatedNCT04933916

EMB-001 as a Potential Smoking Cessation Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Miami Lakes
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Embera NeuroTherapeutics, Inc.
Condition
Addiction
Drug study icon
CompletedNCT01716975

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

Multiple locations, including Phoenixville
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Device study icon
CompletedNCT05809882

Experience of High-frequency Repetitive Transcranial

This study exists to see whether the medication Experience can play a useful role in care. Researchers are trying to understand whether the medication Experience can better support energy, concentration, and everyday functioning.

In Baoding
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
China
Sponsor
Rongjun Hospital of Hebei Province Affiliated to North China University of Science and Technology
Condition
Schizophrenia
Biological study icon
CompletedNCT05216705

Exploratory Plasmatic Markers of Alcohol Withdrawal

This summary needs review. Please check the official study record and contact the research team for details.

In Paris
AddictionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Addiction
Other study type icon
CompletedNCT00472511

Eyes and Attention Deficit (SEAD)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
ADHDOtherFrom 7 Years to 18 Years
Countries
Sponsor
Ohio State University
Condition
ADHD
Other study type icon
CompletedNCT00342953

Health Effects of Cosmetic Breast Augmentation

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
SuicidalityOtherFrom 21 Years to 69 Years
Countries
United States
Sponsor
National Cancer Institute (NCI)
Condition
Suicidality
Drug study icon
CompletedNCT01979133

Icariin for Bipolarity and Co-Occurring Substance Use Disorders

This study exists to explore whether the medication Icariin could improve care and understanding. Researchers are trying to understand whether the medication Icariin can improve attention, thinking, or day-to-day functioning.

In Dallas
Bipolarity, AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.